New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation

Heart FailureTherapy and Intervention

The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation

JACC Heart Fail.

Witte KK, Lipiecki J, Siminiak T, Meredith IT, Malkin CJ, Goldberg SL, Stark MA, von Bardeleben RS, Cremer PC, Jaber WA, Celermajer DS, Kaye DM, Sievert H

doi: 10.1016/j.jchf.2019.06.011.

Heart Failure

Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysis

ESC Heart Fail

Khan MS, Friede T, Anker SD, Butler J

doi: 10.1002/ehf2.13301

Heart Failure

Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial

JAMA Cardiol

Lindenfeld J, Abraham WT, Grayburn PA, Kar S, Asch FM, Lim DS, Nie H, Singhal P, Sundareswaran KS, Weissman NJ, Mack MJ, Stone GW, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Investigators.

doi: 10.1001/jamacardio.2020.7200

Heart, Artery and Coronary DiseasesHeart FailureHypertensionVentricular Function

Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications

Heart

Grayburn PA, Packer M, Sannino A, Stone GW

doi: 10.1136/heartjnl-2020-316992

Heart, Artery and Coronary Diseases

Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study

Lancet.

Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, Deuschl F, Schueler R, Fam NP, Moss R, Makar M, Boone R, Edwards J, Moschovitis A, Kar S, Webb J, Schäfer U, Feldman T, Windecker S

doi: 10.1016/S0140-

Therapy and Intervention

Mid-term hemodynamic and functional results after transcatheter mitral valve leaflet repair with the new PASCAL device

Clin Res Cardiol.

Barth S, Hautmann MB, Arvaniti E, Kikec J, Kerber S, Zacher M, Halbfass P, Ranosch P, Lehmkuhl L, Foldyna B, Lüsebrink U, Hamm K

doi: 10.1007/s00392-020-01733-7.

Heart, Artery and Coronary DiseasesHeart FailureTherapy and Intervention

Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial

J Am Coll Cardiol.

Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG, Mishell JM, Whisenant B, Mack MJ, Lindenfeld J, Abraham WT, Stone GW, Weissman NJ, COAPT Investigators.

doi: 10.1016/j.jacc.2019.09.017.

Therapy and Intervention

Usefulness of Intraprocedural Pulmonary Venous Flow for Predicting Recurrent Mitral Regurgitation and Clinical Outcomes After Percutaneous Mitral Valve Repair With the MitraClip

JACC Cardiovasc Interv.

Ikenaga H, Yoshida J, Hayashi A, Nagaura T, Yamaguchi S, Rader F, Siegel RJ, Kar S, Shiota T

doi: 10.1016/j.jcin.2018.09.034.

Heart, Artery and Coronary Diseases

An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation

JAMA Cardiol.

Gaasch WH, Aurigemma GP, Meyer TE

doi: 10.1001/jamacardio.2019.5980.

Related content